电邮这篇文章 多病种病理患者第一波冠状病毒感染期间自我隔离方案的优缺点
- 作者: Asfandiyarova N.S.1, Filippov E.V.1, Dashkevich O.V.1, Doroshina N.V.1, Suchkova E.I.1, Shehtmester L.I.2
-
隶属关系:
- Ryazan State Medical University named after academician I.P. Pavlov
- Klinikum Süd
- 期: 卷 29, 编号 3 (2021)
- 页面: 364-368
- 栏目: Original study
- URL: https://bakhtiniada.ru/pavlovj/article/view/79388
- DOI: https://doi.org/10.17816/PAVLOVJ79388
- ID: 79388
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
论证。由于新型冠状病毒感染 (NCI) 的迅速传播，严重形式的发展，尤其是在多病病理 (PMP) 患者中，缺乏资源来确保对患者进行最佳治疗，在许多国家，包括在俄罗斯联邦引入了自我隔离制度（英语：“lockdown”）。多发病会增加死亡风险，尤其是在大流行期间。人口中最脆弱的部分是患有多种慢性病的患者。该群体在自我隔离期间的死亡率数据不足。
目的：研究自我隔离期间 PMF 患者的全因死亡率及其结构，与 NCI 没有直接关系。
材料与方法。研究了 2423 名 PMP 患者（841 名丈夫和 1582 名妻子，年龄在 18 至 99 岁）的门诊记录。在过去三年中确定了患者的死亡率及其原因； 包括一段时间的自我隔离。结果。PMF 患者的全因死亡率为 10.2%，没有统计学上的显着性别差异。PMF 患者的主要死因：循环系统疾病 - 50.8%，肿瘤疾病 - 21.0%，神经系统疾病 - 7.3%。自我隔离期间，全因死亡率增加34.3%（p<0.05），循环系统疾病（尤其是冠心病）患者死亡人数增加19.5% % (p> 0.05)。
结论。记录到在自我隔离期间死亡的 PMF 患者人数有所增加，这可能是由于身体活动受到限制，有可能由专科医生进行检查和会诊。鉴于这组患者的脆弱性，当情况再次发生时，迫切需要制定预防措施
作者简介
Nailya Asfandiyarova
Ryazan State Medical University named after academician I.P. Pavlov
Email: n.asfandiyarova2010@yandex.ru
ORCID iD: 0000-0002-2025-8119
SPIN 代码: 1095-4892
MD, Dr. Sci. (Med.)
俄罗斯联邦, 9, st. High-voltage, Ryazan, 390026Evgenii Filippov
Ryazan State Medical University named after academician I.P. Pavlov
Email: dr.philippov@gmail.com
ORCID iD: 0000-0002-7688-7176
SPIN 代码: 2809-2781
MD, Dr. Sci. (Med.), Associate Professor, Head of polyclinic therapy and preventive medicine
俄罗斯联邦, 9, st. High-voltage, Ryazan, 390026Ol'ga Dashkevich
Ryazan State Medical University named after academician I.P. Pavlov
Email: aprel4@live.ru
ORCID iD: 0000-0002-6383-5078
SPIN 代码: 1123-3725
MD, Cand. Sci. (Med.)
俄罗斯联邦, 9, st. High-voltage, Ryazan, 390026Natalia Doroshina
Ryazan State Medical University named after academician I.P. Pavlov
Email: ndoroshina@mail.ru
ORCID iD: 0000-0001-6246-0633
SPIN 代码: 1142-0681
MD
俄罗斯联邦, 9, st. High-voltage, Ryazan, 390026Ekaterina Suchkova
Ryazan State Medical University named after academician I.P. Pavlov
Email: katya.suchkova.1990@mail.ru
ORCID iD: 0000-0002-7997-0338
SPIN 代码: 7506-6232
MD, Cand. Sci. (Med.)
俄罗斯联邦, 9, st. High-voltage, Ryazan, 390026Leonid Shehtmester
Klinikum Süd
编辑信件的主要联系方式.
Email: dr.shehtmester@yahoo.com
ORCID iD: 0000-0002-0309-0238
德国, Nurenberg
参考
- Demograficheskaya situatsiya v Ryazanskoy oblasti za yanvar’–dekabr’ 2021 goda. Available at: https://ryazan.gks.ru/folder/47978. Accessed: 2021 July 01.
- Statistika smertnosti po dannym Rosstat. Available at: https://rosinfostat.ru/smertnost//. Accessed: 2021 July 01.
- The top 10 causes of death. Available at: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed: 2021 July 01.
- Fillenbaum G, Pieper CF, Cohen HJ, et al. Comorbidity of five chronic health conditions in elderly community residents: determinants and impact on mortality. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2000;55(2):M84–98. doi: 10.1093/gerona/55.2.m84
- Zekry D, Valle BHL, Lardi C, et al. Geriatrics index of comorbidity was the most accurate predictor of death in geriatric hospital among six comorbidity scores. Journal of Clinical Epidemiology. 2010;63(9):1036–44. doi: 10.1016/j.jclinepi.2009.11.013
- Larina VN, Bart BYa, Karpenko DG, et al. Polymorbidity and its association with the unfavorable course of chronic heart failure in outpatients aged 60 years and older. Kardiologiia. 2019;59(12S):25–36. (In Russ). doi: 10.18087/cardio.n431
- Malchikova SV, Maksimchuk-Kolobova NS, Kazakovtseva MV. Comorbidity in elderly patients with atrial fibrillation affects the “costofillness”. Farmakoekonomika. Modern Pharmacoeconomic and Pharmacoepidemiology. 2019;12(3):191–9. (In Russ). doi: 10.17749/2070-4909.2019.12.3.191-199
- Khominets VV. Obshchiy analiz smertnosti v Ryazanskoy oblasti 12 mesyatsev 2019 goda. Available at: https://tfoms-rzn.ru/images/files/koord_sovet/2020/3/1.pdf. Accessed: 2021 July 01.
- Yakushin SS, Filippov EV. The main directions of the primary prevention of cardiovascular diseases. Nauka Molodykh (Eruditio Juvenium). 2014;(4):55–68. (In Russ).
- Parshikova EN, Filippov EV. Mortality from all causes in patients with myocardial infarction with elevation of ST segment depending on the type of reperfusion therapy (data of Ryazan region, 2018–2020). I.P. Pavlov Russian Medical Biological Herald. 2020;28(4):479–87. (In Russ). doi: 10.23888/PAVLOVJ2020284479-487
- Wu J, Mamas MA, Mohamed MO, et al. Place and causes of acute cardiovascular mortality during the COVID-19 pandemic. Heart. 2021;107(2):113–9. doi: 10.1136/heartjnl-2020-317912
- Butt JH, Fosbøl EL, Gerds TA, et al. All-Cause Mortality and Location of Death in Patients With Established Cardiovascular Disease Before, During, and After the COVID-19 Lockdown: A Danish Nationwide Cohort Study. European Heart Journal. 2021;42(15):1516–23. doi: 10.1093/eurheartj/ehab028
- Alsallakh MA, Sivakumaran S, Kennedy S, et al. Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales. BMC Medicine. 2021;19(1):124. doi: 10.1186/s12916-021-02000-w
- Vremennyye metodicheskiye rekomendatsii. Profilaktika, diagnostika i lecheniye novoy koronavirusnoy infektsii (COVID-19). Versiya 11 (07.05.2021). Available at: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/055/735/original/B%D0%9C%D0%A0_COVID-19.pdf. Accessed: 2021 July 01.
